European Journal of Cancer · 2014 · 34 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyOncology PharmacotherapySolid Tumor PharmacotherapyMalignant NeoplasmsMtor Inhibitor TherapyOncology PharmacologyPharmacodynamics Of Anticancer DrugsTyrosine Kinase InhibitorsCancer Cell Proliferation InhibitionErlotinib TherapyEverolimus TreatmentEverolimus-based RegimensSorafenib TherapyTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase Inhibitor Therapy
16